Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Herpes simplex virus glycoprotein B (gB) is an essential viral envelope protein that mediates the fusion of the viral envelope with host cell membranes during viral entry. It is a highly conserved protein found in all herpesviruses and plays a critical role in infectivity and pathogenesis. gB acts as the primary fusogen, undergoing large conformational changes to drive membrane merger. It functions as part of a core fusion machinery along with glycoproteins gD, gH, and gL. Neutralizing antibodies targeting gB are crucial for vaccine design and therapeutic antibody development.
Inhibition of viral entry by preventing membrane fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes Simplex Virus Glycoprotein B (gB).